A comprehensive structural analysis of an enhancer sequence frcm bovine papillcma virus DNA is presented based on the construction and functional analysis of 20 mutant derivatives. The results, obtained in CV-1 tissue culture cells, show that this enhancer is a small genetic element -only 40 bp in length -that contains two essential regions. The two regions exhibit homology to each other and to DNA fragments from other viral genomes that also act as enhancers in the assay used. However, there is a certain latitude in the sequences that have enhancer activity in CV-1 cells, even within the critical regions. The results are discussed with respect to the model that enhancers are binding sites for tissue specific transcription factors. The formation of Z-DNA might be involved in the enhancement process. HDwever, single base pair transitions in an 8 base pair stretch of alternating purines and pyrimidines within the BPV enhancer which conserve this pattern destroy enhancer function.
INTRODUCTION
Gene expression in eukaryotes can be regulated at the level of initiation of RNA synthesis at promoters, the sites of specific interaction between RNA polymerase and DNA. Detailed mutational analyses of different promoters for RNA polymerase II allowed the definition of a eukaryotic promoter as a tripartite structure spanning approximately 120 base pairs just upstream of the RNA initiation site (1, 2) . For efficient expression of many genes in mammalian cells, however, additional cis acting DNA elements, termed enhancer sequences, are required. These elements are signals that enhance the rate of transcription initiation at a given promoter in a given genetic environment (3) (4) (5) .
They are unusual in that although they are cis acting, they occur and function in nature in different positions and orientations relative to the promoter they act upon (6) (7) (8) (9) (10) (11) (12) . Furthermore, when present on plasraids, they can be used to activate transcription from heteroloyous promoters (3, 13) . Qihancers have been found in viral genomes such as SV40 (3, 6, 8) , Rjlycma (4), Bovine papillcma virus (10) , retroviral LTRs (14, 15) and also in cellular DNA (11, 12, 16) .
In general, enhancers display cell type specificity; that is, they function more efficiently in sane cells than in others (10) (11) (12) (15) (16) (17) .
Enhancer function can be assayed directly or indirectly in a number of ways. First, gene expression can be directly monitored by measuring the levels of RNA, protein or enzymatic activity produced transiently after introduction of suitable indicator genes into cells. Second, the efficiency with which a given cell line is transformed by DNA carrying a selectable marker can be used to measure enhancer activity; if expression and not integration of the marker CNA into the chromosome is the limiting step in this process (18, 19) .
Following the discovery of enhancer elements in many different systems, the question arose whether conserved sequences could be identified that account for the enhancing effect. Comparison of the DNA sequences characterized as enhancer elements in different systems revealed little homology, suggesting that the sequence requirements differ from cell type to cell type (15) . However, on the basis of both sequence comparisons between different enhancers and a functional analysis of mutants within the SV40 enhancer, a socalled core sequence has been identified as a characteristic feature of an enhancer sequence (20) . This cctamer sequence, CTGG A /I A A A A G (or C T /A T /A T /A CCAC in the complementary DMA strand), has been found to be quite conserved -7 out of 8 nucleotides -between the viral enhancer elements of Polyona, SV40, Bovine papilloma virus, Moloney sarcoma virus and the lymphocyte specific cellular enhancer sequence within an immunoglobulin heavy chain gene (11, 12) .
The aim of this work was a comprehensive structural analysis of an enhancer sequence that had been previously identified on the 8 Kb genome of Bovine papilloma virus 1 (BPV-1). This element is located on a 60 bp restriction fragment 3" to a gene cluster that is expressed early after infection of bovine epithelial cells as well as in rodent tissue culture cells morphologically transformed by the virus (21, 22) . In vivo and in mouse C127 tissue culture cells, the viral DNA is stably maintained as a multicopy nuclear plasmid (23 ants. Single colonies were picked, and plasraid CNA was prepared and tested in the replication assay. To assure the clonal character of the putative enhancer mutants and the intactness of the SV40 early region, the plasraids were recorabined jji vitro with a wild type SV40 early region using the enzymes SphI and BamHI (see Fig. 1 ). However, original and recorabined plasraids of each mutant did not differ in their behavior in the replication assay, indicating not only the clonality of the nutants in the original K.58 cells but also the site specificity of the mutagenesis procedure.
DNA Sequence Analysis
The DNA sequence analysis was carried out using either the base specific chemical cleavage method (32) or the chain termination method (33) . In the latter case, dideoxynucleotides (PL Biochemicals) were used as chain terminators and a synthetic 13 mer oligonucleotide (kindly provided by Peter Seeburg, Genentech, Inc.) representing the nucleotides 4310 to 4322 of p6R322 (34) served as primer for CNA synthesis on NaOH denatured plasmid templates.
RESULTS
To screen different restriction fragments or mutants thereof for enhancer activity, we used an indirect assay for SV40 T antigen expression which has been previously described (10) . Briefly, plasraids that contain the SV40 (20) . However, at least in SV40, the homologous sequences alone cannot account for enhancer function, since a deletion of the nonhomologous region from pos. 186-199 destroys enhancer activity (see Fig. 2 ).
Mutaqenesis of the BPV Enhancer
After we located the enhancer activity on the 60 bp Sau3A restriction fragment of BPV CNA described above, we were interested in identifying the nucleotides critical for the enhancer function within this fragment. Following an experimental design developed by McKnight and Kingsbury (1),. a set of linker scanning mutants was constructed. As a first step, two sets of exonuc- Bottom: Scheme for the generation of heteroduplex molecules specifically single stranded in preselected sites as required for the single strand specific bisulfite nutagenesis protocol described in experimental procedures. The site selection is done by the choice of the appropriate LS mutant used for heteroduplex formation with pl903. lease deletion nutants were generated from either the EcoRI site or the BamHI site of plasmid pl903 (see Fig. 3 ), and Clal linkers were added at the endpoints of the deletions. In order to map the size of the deletions, the resulting nutant plasraids were subjected to sequence analysis. In a second step, deletion nutants from both ends were recombined jri vitro using the Clal sites. In this process, mutants were chosen that conpleraent each other so that the resulting plasraids carry the Clal linker as an internal substitution within the original sequence (for example see plasraids pLS835 and pLS1943 in Fig. 3 ). If within a collection of deletion mutants such complementary nutants are not available, imperfect combinations can be used to produce nutants that carry small deletions or insertions in addition to the linker substitution (see pLS947 and pLS2339 in Fig. 3) . The deletion mutants, as well as the linker scanning mutants, were subsequently analyzed for enhancer activity in the replication assay. A total of 24 deletions were tested, and the two smallest functional deletion mutants from either side, pDIO and pD37 (see Fig. 5 for the single-strand specific nutagen sodium bisulfite, which very efficiently converts C residues to U residues in vitro (31, 42) . Mutagen treated heteroduplexes establish c /3 to T /A transition mutations after being transfected into uracil repair deficient E^. coli strains (ung~). Linear homoduplexes, also formed in this procedure, transform with much lower efficiency than the heteroduplex circles. Therefore, given extensive rautagenic treatment, the mutant yield can be as high as 100%. Another advantage of this protocol is that, as shown below, it dees not require precise linker scanning mutants in order to direct nutagenesis to a specific region, but allows the use of imprecise linker insertion derivatives such as pLS947 and pLS2339 (see Fig. 3 ).
Applying this nutagenesis procedure to hybrids between plasraid pl903 and the pLS plasraids 835, 1943, 947, and 2339 shown in Fig. 3, a FIGURE 5 . Nucleotide sequence eind function of 19 point taitants and two deletion derivatives of the BPV enhancer. Deviations from the original sequence in pl903 (top line) are indicated by boxes. On the bottom line the two enhancer domains, as derived from the analysis of the nutation sites and the function of the different taitants, are pointed out. D10 and D37 are deletion derivatives of pl903; D37 was deleted with exonuclease fran the EcoRI site of pl903 ( Figure 3 ) and a Clal linker (CATCGATG) was added onto pos. 4395. D10 was deleted analogously, but from the BamHI site of pl903, and the linker was added on to pos. 4428 in this case. Plasmid or SV40 specific sequences that had also been deleted in the exonuclease reaction were subsequently restored by combining the deleted plasraid with pJYMASph sequences using the enzymes Clal and SphI (see Fig. 1 ). Note that the wt. sequence in pl903 differs from the BPV sequence published by Chen et_ al. (22) in two positions (4398 and 4417, G vs. A in both cases).
(in p2, p3, p4 and p51) inactivate the function and so define essential nucleotides within the enhancer region. In addition, the nonfunctional single and remains unchanged. Therefore, we conclude that a potential for Z-DNA formation is not sufficient for the functionality of this enhancer domain, since the analysis clearly reveals the requirement of a specific sequence in this region (see p2, p3, p4, p5). Finally, it should be pointed out that some fragments which provide enhancer function do not contain significant stretches of alternating purines and pyrimidines. These include the polyoma enhancer fragment analyzed in this study (see Fig. 2 ) as well as the lymphocyte specif- We furthermore find the reiterated nature of the two functional domains intriguing with respect to how a putative protein might recognize this sequence.
The apparent latitude in the sequences that can function as enhancers in CV-1 cells is remarkable. As pointed out in the Results section, p6 carries an altered but functional enhancer sequence. It can be viewed as a compensating revertant of either p4 or p53, both of which are enhancer deficient (see H. W. thanks Dr. S. Oonrad for most valuable discussions, encouragement and substantial contributions to the manuscript. We further thank Drs. H.
